我国上市的藏成药概况分析  

Overview Analysis of Tibetan Medicines on the Market in China

作　　者：索朗央宗[1] 泽碧[1] 胡扬 贡却拉姆[3] 德吉 刘莉[1] Suolangyangzong;Zebi;HU Yang;Gongquelamu;Deji;LIU Li(Depatment of Phamacy,Xizang Autonomous Region People′s Hospital,Lhasa 850000,China;Depatment of Phamacy,Peking Union Medical College Hospital,Chinese Academy of Medical Sciences,Beijing 100730,China;Teaching and Research Section,University of Xizang Medicine,Lhasa 850000,China)

机构地区：[1]西藏自治区人民医院药学部,拉萨850000 [2]中国医学科学院北京协和医院药剂科,北京100730 [3]西藏藏医药大学教研室,拉萨850000

出　　处：《中国药学杂志》2024年第22期2191-2196,共6页Chinese Pharmaceutical Journal

摘　　要：目的了解上市藏成药整体情况,为探索藏成药综合评价的方法打基础。方法检索国家药品监督管理局药品信息网,提取数据,从生产厂家、藏成药品种数量等维度进行分析。结果纳入藏成药373条目,排除80(中成药)条目,涉及生产厂家19家,涉及藏成药不同剂型品种数182种。藏成药保护品种保护级别国药准字涉及品种16种,省级标准文号涉及品种16种。系统治疗疾病分类主要集中在治疗胃肠道病症类药物、治疗皮肤、黄水症及风湿类药物、治疗肝脏病症类药品。结论藏成药综合评价药品目录可以从保护品种、生产厂家多品种、药品主要疾病分类等维度分步骤按照中成药已有的评价方法尝试进行单个品种试点的综合评价研究。首批品种为二十五味松石丸、二十五味珊瑚丸、二十五味珍珠丸、二十五味鬼臼丸、智托洁白丸、十五味黑药丸、七十味珍珠丸、仁青常觉、珊瑚七十味丸、消痛贴膏、诺迪康胶囊。OBJECTIVE To understand the overall situation of Tibetan medicines on the market,and to explore the method of comprehensive evaluation of Tibetan medicines.METHODS Data were extracted from the drug information network of the State Drug Administration and analyzed from the dimensions of manufacturers and varieties of Tibetan medicines.RESULTS The 373 items of proprietary Tibetan medicine were included,80 items(proprietary Chinese medicine)were excluded,19 manufacturers were involved,and 182 different dosage forms of proprietary Tibetan medicine were involved.The protection level of Tibetan patent medicine protection varieties includes 16 varieties,and the provincial standard document number involves 16 varieties.The classification of systemic treatment diseases is mainly concentrated in the treatment of gastrointestinal diseases,the treatment of skin,yellow water and rheumatic drugs,the treatment of liver diseases.CONCLUSION The preliminary comprehensive evaluation catalogue of proprietary Tibetan medicines can be conducted in steps according to the existing evaluation methods of proprietary Chinese medicines in terms of protected varieties,multi-varieties of manufacturers and classification of major diseases.The first batch of varieties include 25 Flavor Song shi pills,25 Flavor Coral pills,25 Flavor Pearl pills,25 Flavor Guijiu pills,Zhituo Jiebai pills,15 Flavor Black pills,70 Flavor Pearl pills,Renqing Changjue,Coral 70 Flavor pills,Pain Relieving patch,and Nodikon capsules.

关 键 词：藏成药 综合评价 遴选目录 上市 

分 类 号：R95[医药卫生—药学]